A Phase II Study of Photodynamic Therapy (PDT) With Photofrin (IND 104,613) For Recurrent High Grade Gliomas in Adults

Trial Profile

A Phase II Study of Photodynamic Therapy (PDT) With Photofrin (IND 104,613) For Recurrent High Grade Gliomas in Adults

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 02 Nov 2017

At a glance

  • Drugs Porfimer sodium (Primary)
  • Indications Glioma
  • Focus Therapeutic Use
  • Acronyms PDT for BT
  • Most Recent Events

    • 27 Oct 2017 Status changed from recruiting to active, no longer recruiting.
    • 10 Oct 2016 Status changed from active, no longer recruiting to recruiting.
    • 10 Feb 2016 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top